European Pharmaceutical Review
FEBRUARY 25, 2025
Scientists have developed a new, potentially safer method to produce ethylene oxide. Based on the proposed technique, adding small amounts of nickel atoms to silver catalysts can maintain production efficiency while eliminating the need for chlorine, leading to a reduced environmental impact for ethylene oxide manufacturing. What sparked this development?
The Checkup by Singlecare
FEBRUARY 25, 2025
Linzess (linaclotide) is a brand-name medication that has long been FDA approved to treat chronic constipation from irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). In 2023, the FDA also approved Linzess as the first treatment for pediatric functional constipation, a condition in children and adolescents that causes infrequent bowel movements and hard stools that are difficult to pass.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
FEBRUARY 25, 2025
The tiny number of Indigenous students in U.S. medical schools has long been a concern, but Native American medical leaders were taken aback to see 22% fewer American Indian or Alaska Native students had enrolled last year when numbers were released in January. “It’s pathetic, isn’t it? It’s so small,” said Donald Warne, a Lakota physician and co-director of the Center for Indigenous Health at the Johns Hopkins Bloomberg School of Public Health, as he looked cl
Drug Topics
FEBRUARY 25, 2025
Miudella achieves similar efficacy to other available copper IUDs with less than half the dose of copper.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
STAT
FEBRUARY 25, 2025
Since the end of World War II, the business plan of American universities has included two key principles that now are undergoing rapid disruptive change: Student-athletes participate in college sports in exchange for tuition, room, and board. Federal funding for academic research is the primary engine for the nation’s basic science enterprise.
Drug Topics
FEBRUARY 25, 2025
The increased risk of symptoms only includes respiratory-related symptoms or brain fog.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
FEBRUARY 25, 2025
The results of this study show that the concurrent presence of asthma and obesity did not synergistically amplify inflammation in children with both asthma and overweight/obesity.
STAT
FEBRUARY 25, 2025
Rise and shine, everyone, another busy day is on the way. We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the number of motor vehicles passing by our window. As for us, we are trying to slow things down by engaging in the usual ritual of brewing cups of stimulation.
Drug Topics
FEBRUARY 25, 2025
Among postmenopausal women, researchers investigated the association of cardiometabolic parameters and circulating levels of visfatin, adropin, and adiponectin.
STAT
FEBRUARY 25, 2025
Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from cheap, compounded copies of weight loss medications. Zepbound was originally sold in injectable pens at a list price of about $1,000 per month, but Lilly last year launched the lowest doses of the medication, 2.5 milligrams and 5 milligrams, in vials at $399 and $549 a month.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
FEBRUARY 25, 2025
Crystal Zhou, PharmD, APh, AHSCP, BCACP, joined Drug Topics to further discuss the Cut Hypertension Program and nontraditional roles within health care.
STAT
FEBRUARY 25, 2025
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Last Thursday, Rep. Ro Khanna (D-Calif.) posted a video on TikTok informing his 400,000 followers of “breaking news” that “the Trump administration announced that Medicare will stop covering telehealth on April 1st,” and calling for opposition to
Drug Topics
FEBRUARY 25, 2025
The technology will be available to patients in the United States in March 2025.
STAT
FEBRUARY 25, 2025
After a top UnitedHealth Group executive was gunned down in New York City in December , the company’s risk intelligence team combed the internet for new threats. It didn’t take long to find them. The night of the shooting, a chilling entry appeared at the bottom of another executive’s LinkedIn post: “You’re next.” The following morning, Minnetonka police interviewed that executive at the company’s office in the otherwise sleepy, snow-covered Minne
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Fierce Healthcare
FEBRUARY 25, 2025
Republican holdouts, who stated repeatedly they would not vote for the bill, ultimately opted to advance legislation which will require significant Medicaid cuts.
STAT
FEBRUARY 25, 2025
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick recently. It’s a particularly intense flu season right now. Hope everyone is taking care of themselves.
PharmaVoice
FEBRUARY 25, 2025
Cavazzoni stepped down from her role as head of the FDA’s main drug review office in mid-January. She will succeed Aida Habtezion.
STAT
FEBRUARY 25, 2025
Hello and happy Tuesday, D.C. Diagnosis readers! This week we find out whether House Republicans are willing to take the first steps towards Medicaid cuts. What are you hearing about the budget battles underway? Send news and tips to sarah.owermohle@statnews.com. Trump administration quietly rehires FDA staff The Trump administration has started rehiring some of the FDA employees it fired last week, the latest chapter in a haphazard and confusing layoff process, agency sources tell Lizzy L
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
pharmaphorum
FEBRUARY 25, 2025
Ten out of 11 children with congenital deafness treated with a gene therapy developed by Regeneron have seen "notable" improvements in hearing
STAT
FEBRUARY 25, 2025
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Everyone’s talking about egg prices, but what I’m most worried about is my apartment’s heating bill. Apparently I’m not alone.
PharmaVoice
FEBRUARY 25, 2025
Orphan drug development has long been incentivized by government policy. But as the financial math shifts, so do the risks of bringing rare disease drugs to market.
Fierce Healthcare
FEBRUARY 25, 2025
It was the late 2000s. The Apple iPhone had recently been introduced and on-demand music libraries were becoming popular. | Because demand for mental healthcare is high, experts say, there is a need for innovative tools to help broaden access to music therapy.
Pharmaceutical Technology
FEBRUARY 25, 2025
Samsung Bioepis has now allegedly sub-licensed its Stelara biosimilar rights to a health conglomerate, breaching a previous settlement.
Pharmacy Times
FEBRUARY 25, 2025
Levonorgestrel-releasing intrauterine devices were not found to increase womens risks of these conditions.
pharmaphorum
FEBRUARY 25, 2025
In a move that will raise eyebrows in Washington, Pfizer has hired former FDA director Patricia Cavazzoni as its new chief medical officer
Pharmacy Times
FEBRUARY 25, 2025
The label changes to buprenorphine extended-release injections can increase convenience and adherence for patients with moderate to severe opioid use disorder.
The Checkup by Singlecare
FEBRUARY 25, 2025
Semaglutide, sold under brand names like Ozempic, Rybelsus, and Wegovy, are newer medications treating Type 2 diabetes and obesity. The prescription drug has quickly grown in popularity due to its weight management abilities. In fact, its become so popular that the demand for compounded semaglutide formulas has grown significantly for its lower price (though reports show its not as safe as the name brand and generic options).
Pharmacy Times
FEBRUARY 25, 2025
According to Pranav Garimella, pharmacists are essential in counseling patients with CKD on the appropriate use of semaglutide.
Pharmaceutical Technology
FEBRUARY 25, 2025
Gilead Sciences has announced EMA validation for a parallel accelerated review of lenacapavirs MAA and EU-M4all applications.
Pharmacy Times
FEBRUARY 25, 2025
The administration of immunotherapy in adjuvant, neoadjuvant, and perioperative settings offers distinct benefits and challenges in resectable cancers, with recent clinical trials highlighting its potential to improve long-term outcomes and the need for further research into biomarkers and combination strategies.
Pharmaceutical Technology
FEBRUARY 25, 2025
Entrada plans to initiate the Phase Ib study of ENTR-601-44 in the US in the first half of next year.
Pharmacy Times
FEBRUARY 25, 2025
Phil Vigeant shares benefits and considerations of plant-based protein powders, highlighting the pharmacist's role in recommending quality plant-based protein powders.
pharmaphorum
FEBRUARY 25, 2025
Former UK Prime Minister Rishi Sunak has joined Prostate Cancer Research as an ambassador for its campaign for a national screening programme.
Expert insights. Personalized for you.
Let's personalize your content